Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2021-11-30 Capital/Financing Update
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement - Amendment) filed with the Financial Services Commission (FSC) in South Korea. It details the finalization of the offering price for ToolGen's stock issuance. This type of document is a formal regulatory filing required for public offerings and capital raising activities. Since it is a specific regulatory filing related to share issuance and capital structure, it falls under the 'Capital/Financing Update' category.
2021-11-30 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Capital Increase Decision' (유상증자결정) for the company ToolGen. It is a formal regulatory filing submitted to the Korean financial authorities (as indicated by the Korean language and the specific format of the report). It details changes to the capital increase plan, including adjustments to the issuance price, funding purposes, and subscription details. This falls under the category of 'Share Issue/Capital Change' (SHA) as it pertains to the issuance of new shares and the associated capital structure changes.
2021-11-30 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 1% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서) filed by ToolGen. It details specific changes to the offering price, total offering amount, and share allocation ratios following the determination of the final public offering price. In the context of financial filings, a prospectus or its amendment (correction) is a primary regulatory document for capital raising, which falls under the 'Regulatory Filings' category as it does not fit into the specific categories like 10-K, ER, or IP.
2021-11-30 Korean
투자설명서
Investor Presentation Classification · 1% confidence The document is a '투자설명서' (Investment Prospectus) for ToolGen, dated November 25, 2021. It details the offering of 1,000,000 shares, subscription periods, and investment risks associated with the company's IPO or capital raise. In the context of financial filings, a prospectus is a primary document for a securities offering, which falls under the 'Proxy Solicitation & Information Statement' (PSI) category in this schema, as it serves as the formal disclosure document provided to potential investors for their decision-making process.
2021-11-25 Korean
기업설명회(IR)개최결과
Report Publication Announcement Classification · 1% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) event held by ToolGen. It provides the date, location, attendees, and a summary of the topics covered (company status, outlook, Q&A). Since it is a brief notification of an event that has already occurred rather than the full presentation deck itself, and it follows the standard format for regulatory event disclosures, it is classified as a Regulatory Filing (RNS).
2021-11-22 Korean
[기재정정]증권신고서(지분증권) (2021.12)
Capital/Financing Update Classification · 1% confidence The document is a '증권신고서(지분증권) 정정신고' (Amendment to Securities Registration Statement) filed by ToolGen. It explicitly mentions '정정대상 공시서류' (Amendment target disclosure document) and details specific sections being updated, such as investment risks, business activities, and financial information. This is a formal regulatory filing required for public offerings or significant changes to registration statements in the Korean market. It does not fit into the other specific categories like 10-K or ER, and is a primary regulatory document rather than an announcement of a report.
2021-11-17 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.